24 Apr, 2017, 11:12 ET
CRANBURY, N.J., April 24, 2017 /PRNewswire/ -- Physicians' Education Resource® (PER®) announces a collaboration with Norwegian Lung Cancer Group for PER®'s 1st Annual European Symposium on Lung Cancers™. The event will be held July 7-8 in Barcelona, Spain.
In making the announcement, Phil Talamo, president of PER®, said, "We are excited to work in collaboration with Norwegian Lung Cancer Group. Together, we aim to provide our attendees with the upmost information from the field of lung cancer therapy to optimize care for their patients."
Norwegian Lung Cancer Group is a medical specialty forum that promotes lung cancer prevention and ensures quality care for patients. The collaborative partnership will provide attendees with information on disruptive therapeutic innovations in lung cancer and new approaches towards cancer treatments.
The 1st Annual European Symposium on Lung Cancers™ is a practical and interactive multiday program that features internationally recognized medical experts in lung cancer who will provide information on recent key studies in the field. The agenda for the symposium will focus on immunotherapy with newly diagnosed patients, combinations and new targets, second-line therapy, irAEs and biomarkers. The format will allow participants to engage in specific case-based discussions.
In addition, featured topics for the symposium include: management of immune-related adverse events, clinical data on targeted agents for other oncogenic drivers, including BRAF, MET, and RET, emergence of liquid biopsies for molecular testing, and what oncologists need to know for their optimal application, immunotherapy as a new standard of care in the first-line setting and in previously treated patients, and much more.
The event will be held at Crowne Plaza Barcelona – Fira Center. For more information, please visit Gotoper.com/go/PRNLCG
About PER®:
Since 1995, PER® has been the leading provider of live, online and print continuing medical education activities focusing on oncology and hematology by consistently providing high-quality, evidence-based activities that feature leading international experts who focus on the application of practice-changing advances and evolving standards of care in the treatment and management of cancer. In 2017, PER® will develop and implement more than 21 historic annual legacy conferences in the Unites States and Europe, along with many world renown online learning formats, such as Medical Crossfire®, Oncology Consultations®, Oncology Briefings™, Advances in™, Cancer Summaries and Commentaries™, and others. PER® is also the publisher of the monthly peer-reviewed American Journal of Hematology/Oncology® and is accredited by the ACCME and CBRN to educate practicing academic and community-based clinicians on the ever-changing advances occurring in the field of oncology to serve the oncology health care community, including physicians, fellows, advanced practice nurses, nurses, physician assistants, pharmacists and researchers. PER® is part of the Cranbury, N.J.-based Michael J. Hennessy Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
PER® Media Contacts:
Theresa Burek
[email protected]
Surabhi Verma
[email protected]
